Connecticut 2014 Regular Session

Connecticut Senate Bill SB00191 Latest Draft

Bill / Comm Sub Version Filed 04/16/2014

                            General Assembly  Raised Bill No. 191
February Session, 2014  LCO No. 964
 *_____SB00191PD____041614____*
Referred to Committee on INSURANCE AND REAL ESTATE
Introduced by:
(INS)

General Assembly

Raised Bill No. 191 

February Session, 2014

LCO No. 964

*_____SB00191PD____041614____*

Referred to Committee on INSURANCE AND REAL ESTATE 

Introduced by:

(INS)

AN ACT CONCERNING HEALTH INSURANCE COVERAGE OF ORALLY AND INTRAVENOUSLY ADMINISTERED MEDICATIONS. 

Be it enacted by the Senate and House of Representatives in General Assembly convened:

Section 1. (NEW) (Effective January 1, 2015) Each insurance company, hospital service corporation, medical service corporation, health care center, fraternal benefit society or other entity that delivers, issues for delivery, renews, amends or continues in this state individual health insurance policies providing coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of the general statutes and that provide coverage for intravenously administered medications for the treatment or palliation or therapeutic intervention for the prevention of disabling or life-threatening chronic diseases shall provide coverage for orally administered medications for such treatment, palliation or intervention on a basis no less favorable than intravenously administered medications.

Sec. 2. (NEW) (Effective January 1, 2015) Each insurance company, hospital service corporation, medical service corporation, health care center, fraternal benefit society or other entity that delivers, issues for delivery, renews, amends or continues in this state group health insurance policies providing coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of the general statutes and that provide coverage for intravenously administered medications for the treatment or palliation or therapeutic intervention for the prevention of disabling or life-threatening chronic diseases shall provide coverage for orally administered medications for such treatment, palliation or intervention on a basis no less favorable than intravenously administered medications.

 


This act shall take effect as follows and shall amend the following sections:
Section 1 January 1, 2015 New section
Sec. 2 January 1, 2015 New section

This act shall take effect as follows and shall amend the following sections:

Section 1

January 1, 2015

New section

Sec. 2

January 1, 2015

New section

 

INS Joint Favorable
PD Joint Favorable

INS

Joint Favorable

PD

Joint Favorable